SPR38
SPR38 is a potent SARS-CoV-2 main protease inhibitor, with a Ki of 0.260 μM. SPR38 also inhibits hCatL and hCatB, with Ki values of 1.92 μM and 11.1 μM, respectively[1].
Product Specifications
UNSPSC
12352005
Target
Cathepsin; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/spr38.html
Solubility
10 mM in DMSO
Smiles
O=C(OCC1=CC=CC=C1)N[C@@H](CCCC)C(N[C@H](/C=C/C(C)=O)C[C@H]2C(NCC2)=O)=O
Molecular Formula
C24H33N3O5
Molecular Weight
443.54
References & Citations
[1]Previti S, et al. Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cathepsin B; Cathepsin L
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15400520 1 Vial
Lentiviral human DNAJC3 sgRNA gene knockout kit - Lentiviral human DNAJC3 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details GTR15268514 1 Vial
Lentiviral mouse Tecta shRNA (UAS) - Lentiviral mouse Tecta shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details